See Aquestive Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap

453.09M

Dividend TTM

0.00

P/E TTM

-5.93

EPS TTM

-0.61

Revenue

44.55M

Net Profit

-44.14M

ROE

0.00%

ROA

-56.63%

Aquestive Therapeutics Inc Earnings Date

Latest Release

Nov 3, 2026

EPS / Forecast

-0.13/-0.12

Revenue / Forecast

7.56M/11.02M

Financial Statement Highlights

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q3

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

Financial Indicators

EPS

5.93%-0.13

-34.11%-0.18

72.63%-0.07

-39.54%-0.26

-10.54%-0.14

-351.81%-0.14

-37.79%-0.24

-55.03%-0.19

-301.65%-0.13

70.11%-0.03

-220.16%-0.17

46.84%-0.12

---0.03

---0.10

--0.15

---0.23

---0.90

----

Revenue

-40.99%7.56M

38.15%13.82M

65.67%14.45M

9.67%13.02M

-5.43%12.81M

-50.23%10.00M

-27.65%8.72M

-10.14%11.87M

4.15%13.54M

51.79%20.10M

8.25%12.05M

23.63%13.21M

13.43%13.00M

-0.18%13.24M

-9.26%11.13M

-3.57%10.68M

-13.73%11.46M

-13.55%13.27M

10.32%12.27M

54.96%11.08M

Net Profit

-6.80%-16.50M

-68.76%-22.86M

64.86%-8.06M

-86.81%-31.86M

-34.21%-15.45M

-393.55%-13.55M

-78.75%-22.93M

-110.27%-17.05M

-465.55%-11.51M

52.61%-2.75M

-259.00%-12.83M

34.33%-8.11M

83.77%-2.04M

64.47%-5.79M

161.03%8.07M

57.33%-12.35M

13.87%-12.54M

-31.82%-16.30M

9.90%-13.22M

-42.11%-28.95M

Net Margin

-80.99%-218.29%

-22.16%-165.45%

78.79%-55.77%

-70.33%-244.79%

-41.91%-120.61%

-891.69%-135.44%

-147.07%-262.96%

-134.00%-143.72%

-443.00%-84.99%

68.78%-13.66%

-246.88%-106.43%

46.88%-61.42%

---15.65%

---43.74%

--72.46%

---115.63%

---113.68%

----

Gross Margin

-19.34%52.28%

30.38%70.93%

30.74%75.99%

-10.91%55.16%

-3.60%64.82%

-29.78%54.40%

-8.60%58.12%

-4.12%61.91%

6.56%67.24%

54.88%77.48%

10.67%63.59%

28.27%64.57%

--63.10%

--50.03%

--57.45%

--50.34%

--61.94%

----

Debt to assets ratio

57.10%118.87%

185.05%106.54%

176.18%91.24%

145.84%78.84%

165.99%75.66%

46.37%37.38%

48.66%33.03%

-33.11%32.07%

-56.82%28.45%

-62.84%25.53%

-67.87%22.22%

-47.53%47.95%

--65.87%

--68.71%

--69.17%

--91.38%

--102.03%

----

Income Statement

Revenue

-40.99%7.56M

38.15%13.82M

65.67%14.45M

9.67%13.02M

-5.43%12.81M

-50.23%10.00M

-27.65%8.72M

-10.14%11.87M

4.15%13.54M

51.79%20.10M

8.25%12.05M

23.63%13.21M

13.43%13.00M

-0.18%13.24M

-9.26%11.13M

-3.57%10.68M

-13.73%11.46M

-13.55%13.27M

10.32%12.27M

54.96%11.08M

Operating profit

-26.05%-14.47M

27.67%-8.22M

78.29%-4.20M

-112.38%-28.84M

-38.47%-11.48M

-20769.09%-11.37M

-116.20%-19.36M

-247.20%-13.58M

-248.76%-8.29M

101.31%55.00K

-94.51%-8.96M

63.49%-3.91M

73.15%-2.38M

67.02%-4.21M

52.71%-4.61M

8.19%-10.71M

-11.11%-8.85M

-95.83%-12.76M

-14.23%-9.74M

25.42%-11.67M

Net Profit

-6.80%-16.50M

-68.76%-22.86M

64.86%-8.06M

-86.81%-31.86M

-34.21%-15.45M

-393.55%-13.55M

-78.75%-22.93M

-110.27%-17.05M

-465.55%-11.51M

52.61%-2.75M

-259.00%-12.83M

34.33%-8.11M

83.77%-2.04M

64.47%-5.79M

161.03%8.07M

57.33%-12.35M

13.87%-12.54M

-31.82%-16.30M

9.90%-13.22M

-42.11%-28.95M

Balance Sheet

Current assets

-30.23%105.83M

45.00%118.49M

46.00%130.18M

69.20%149.27M

57.06%151.67M

-21.43%81.72M

-21.35%89.17M

115.35%88.22M

127.45%96.57M

161.41%104.01M

159.41%113.38M

2.70%40.97M

11.47%42.46M

-8.54%39.79M

2.63%43.71M

-15.60%39.89M

-24.14%38.09M

-14.69%43.51M

-4.18%42.59M

5.90%47.26M

Total current liabilities

-32.36%17.30M

-28.84%16.48M

73.53%31.75M

152.36%47.61M

68.78%25.57M

66.64%23.16M

1.33%18.30M

3.04%18.86M

-37.02%15.15M

-64.05%13.89M

-55.28%18.06M

-53.68%18.31M

-34.20%24.06M

30.43%38.65M

66.98%40.38M

79.97%39.53M

46.01%36.56M

28.66%29.64M

20.62%24.18M

4.08%21.96M

Total assets

-27.04%119.33M

40.99%132.10M

38.04%141.13M

58.17%160.43M

48.75%163.56M

-20.33%93.70M

-21.07%102.23M

76.64%101.42M

84.97%109.96M

106.35%117.61M

111.35%129.52M

0.61%57.42M

14.66%59.45M

1.21%56.99M

8.41%61.28M

-7.94%57.07M

-20.60%51.84M

-15.80%56.31M

-8.71%56.53M

-1.42%61.99M

Total liabilities

13.41%190.15M

13.47%188.69M

7.36%175.18M

20.12%194.09M

7.91%167.67M

8.63%166.29M

-1.60%163.16M

-1.42%161.58M

-4.31%155.38M

-6.45%153.08M

-2.75%165.82M

-6.67%163.91M

1.70%162.38M

7.19%163.65M

13.93%170.52M

21.85%175.62M

27.08%159.66M

26.54%152.67M

31.61%149.67M

29.40%144.13M

Total equity

-1623.63%-70.82M

22.05%-56.59M

44.11%-34.05M

44.04%-33.66M

90.95%-4.11M

-104.60%-72.59M

-67.85%-60.93M

43.51%-60.16M

55.87%-45.42M

66.73%-35.48M

66.77%-36.30M

10.18%-106.49M

4.54%-102.93M

-10.68%-106.65M

-17.28%-109.23M

-44.34%-118.55M

-78.67%-107.82M

-79.21%-96.36M

-79.82%-93.14M

-69.36%-82.13M

Cash Flow Statement

Net operating income

44.30%-7.05M

-19.29%-9.44M

36.73%-14.81M

-30.51%-8.47M

-6.47%-12.65M

-12.96%-7.91M

-125.35%-23.40M

-31.30%-6.49M

-406.18%-11.88M

11.39%-7.01M

-217.79%-10.38M

-158.51%-4.94M

-183.55%-2.35M

-20.50%-7.91M

160.88%8.82M

204.78%8.45M

130.99%2.81M

-273.69%-6.56M

-2.73%-14.48M

40.34%-8.06M

Net investment

-148.51%-584.00K

-98.13%-212.00K

61.48%-52.00K

-466.67%-85.00K

-193.75%-235.00K

-205.71%-107.00K

-365.52%-135.00K

6.25%-15.00K

47.02%-80.00K

95.76%-35.00K

-1350.00%-29.00K

38.46%-16.00K

91.21%-151.00K

-22.01%-826.00K

98.08%-2.00K

95.12%-26.00K

-1968.67%-1.72M

-248.97%-677.00K

-0.97%-104.00K

-125.85%-533.00K

Net financing

-100.63%-511.00K

-2491.00%-2.59M

-78.58%4.42M

320.38%660.00K

478988.24%81.41M

-105.84%-100.00K

-74.74%20.65M

-95.99%157.00K

-100.34%-17.00K

-60.09%1.71M

988.01%81.74M

1818.14%3.91M

3707.97%4.98M

-57.96%4.29M

-809.17%-9.21M

-96.26%204.00K

-102.27%-138.00K

17.41%10.20M

-86.88%1.30M

-80.86%5.45M

Revenue

By Business

Period:

No Data

By Region

Period:

No Data

FAQs

What is the total revenue of Aquestive Therapeutics Inc?



According to Aquestive Therapeutics Inc's FY2025 earnings report, its total revenue reached 44.55M, with a year-on-year change of 57.56M.

What are the current assets of Aquestive Therapeutics Inc?



According to Aquestive Therapeutics Inc's FY2025 earnings report, its current assets were 105.83M, with a year-on-year change of -29.10.

What are the total assets of Aquestive Therapeutics Inc?



According to Aquestive Therapeutics Inc's FY2025 earnings report, its total assets of Aquestive Therapeutics Inc were 119.33M, with a year-on-year change of -25.62.

What are the total liabilities of Aquestive Therapeutics Inc?



According to Aquestive Therapeutics Inc's FY2025 earnings report, its total liabilities of Aquestive Therapeutics Inc were 190.15M, with a year-on-year change of -2.03.

What is the total equity of Aquestive Therapeutics Inc?



According to Aquestive Therapeutics Inc's FY2025 earnings report, its total equity of Aquestive Therapeutics Inc was -70.82M, with a year-on-year change of -110.40.

What is the net operating income of Aquestive Therapeutics Inc?



According to Aquestive Therapeutics Inc's FY2025 earnings report, its net operating income of Aquestive Therapeutics Inc was -71.05M, with a year-on-year change of -130.90.

What is the net investment of Aquestive Therapeutics Inc?



According to Aquestive Therapeutics Inc's FY2025 earnings report, its net investment of Aquestive Therapeutics Inc was -562.00K, with a year-on-year change of -253.46.

What is the net financing of Aquestive Therapeutics Inc?



According to Aquestive Therapeutics Inc's FY2025 earnings report, its net financing of Aquestive Therapeutics Inc was 102.62M, with a year-on-year change of 22.76.

What is the net income of Aquestive Therapeutics Inc?



According to Aquestive Therapeutics Inc's FY2025 earnings report, its net income was -83.78M, with a year-on-year change of -89.83.

What is the debt-to-asset ratio of Aquestive Therapeutics Inc?



According to Aquestive Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 118.87, with a year-on-year change of 50.77.

What is the operating profit of Aquestive Therapeutics Inc?



According to Aquestive Therapeutics Inc's FY2025 earnings report, its operating profit was -71.05M, with a year-on-year change of -130.90.